USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Cumberland Pharmaceuticals Inc.
Address:
2525 WEST END AVE, STE 950
NASHVILLE, TN 37203-
Phone:
(615) 255-0068
URL:
EIN:
N/A
DUNS:
069532880
Number of Employees:
35
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $246,084.00 1

Award List:

Preclinical Development of a New Drug for Treating Anemia of Chronic Inflammation

Award Year / Program / Phase:
2012 / STTR / Phase I
Award Amount:
$246,084.00
Agency:
HHS
Principal Investigator:
Adam N. Goldfarb – 434-982-0593
Research Institution:
UNIVERSITY OF VIRGINIA
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): A strong unmet need exists to develop new treatments for anemias associated with chronic disease states, collectively referred to as anemia of chronic inflammation (ACI). ACI is highly prevalent in the U.S. and makes alarge contribution to public morbidity and… More